138 related articles for article (PubMed ID: 3911374)
1. Decreased red cell deformability and vascular obstruction in falciparum malaria illustrated by a fatal case.
Ahlqvist J
Scand J Haematol; 1985 Nov; 35(5):531-5. PubMed ID: 3911374
[TBL] [Abstract][Full Text] [Related]
2. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
Tan Heng Soon ; Tan Puay Eng
Med J Malaysia; 1983 Sep; 38(3):217-23. PubMed ID: 6369092
[No Abstract] [Full Text] [Related]
3. Fansidar for malaria prophylaxis.
Kissane D
Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
[No Abstract] [Full Text] [Related]
4. Falciparum malaria: the urgent need for safe and effective drugs.
Rieckmann KH
Annu Rev Med; 1983; 34():321-35. PubMed ID: 6344762
[TBL] [Abstract][Full Text] [Related]
5. Falciparum malaria resistant to quinine and pyrimethamine-sulfadoxine successfully treated with mefloquine.
Malin AS; Hall AP
BMJ; 1990 May; 300(6733):1175. PubMed ID: 2189516
[No Abstract] [Full Text] [Related]
6. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
Pearson RD; Hewlett EL
Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
[TBL] [Abstract][Full Text] [Related]
7. RI quinine-Fansidar resistant falciparum malaria from Malawi.
Warhurst DC; Hall AP; Tjokrosonto S
Lancet; 1985 Aug; 2(8450):330. PubMed ID: 2862492
[No Abstract] [Full Text] [Related]
8. Leads from the MMWR. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
JAMA; 1985 Jan; 253(4):483. PubMed ID: 3881605
[No Abstract] [Full Text] [Related]
9. An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
de Souza JM; Sheth UK; de Oliveira RM; Roulet H; de Souza SD
Bull World Health Organ; 1985; 63(3):603-9. PubMed ID: 3899397
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum maturation abolishes physiologic red cell deformability.
Cranston HA; Boylan CW; Carroll GL; Sutera SP; Williamson JR; Gluzman IY; Krogstad DJ
Science; 1984 Jan; 223(4634):400-3. PubMed ID: 6362007
[TBL] [Abstract][Full Text] [Related]
11. Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine.
Hall AP; Doberstyn EB; Mettaprakong V; Sonkom P
Br Med J; 1975 Apr; 2(5961):15-7. PubMed ID: 1093610
[TBL] [Abstract][Full Text] [Related]
12. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
Tin F; Hlaing N; Tun T; Win S; Lasserre R
Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
[TBL] [Abstract][Full Text] [Related]
13. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(14):185-90, 195. PubMed ID: 3156271
[No Abstract] [Full Text] [Related]
14. Therapeutic use of exchange transfusion in malaria.
Roncoroni AJ; Martino OA
Am J Trop Med Hyg; 1979 May; 28(3):440-4. PubMed ID: 378004
[TBL] [Abstract][Full Text] [Related]
15. Leads from the MMWR. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum.
JAMA; 1985 May; 253(17):2483-6. PubMed ID: 3157011
[No Abstract] [Full Text] [Related]
16. Malaria chemoprophylaxis--which drug?
Biddulph J
P N G Med J; 1983 Jun; 26(2):127-30. PubMed ID: 6388184
[No Abstract] [Full Text] [Related]
17. The chemoprophylaxis of malaria.
Chiodini PL
J Antimicrob Chemother; 1987 Sep; 20(3):297-302. PubMed ID: 3316145
[No Abstract] [Full Text] [Related]
18. [Falciparum malaria in East African tourists in spite of fansidar prevention. A contribution on increased chloroquine and pyrimethamine-sulfadoxine resistance in areas of East Africa].
Eichenlaub D; Hoffmann HG; Rögler G; Weise HJ
Dtsch Med Wochenschr; 1983 Mar; 108(9):338-43. PubMed ID: 6337809
[TBL] [Abstract][Full Text] [Related]
19. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
20. Severe cutaneous reactions among American travelers using pyrimethamine-sulfadoxine (Fansidar) for malaria prophylaxis.
Miller KD; Lobel HO; Satriale RF; Kuritsky JN; Stern R; Campbell CC
Am J Trop Med Hyg; 1986 May; 35(3):451-8. PubMed ID: 2939735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
